Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does CASIRIVIMAB\IMDEVIMAB Cause Covid-19 pneumonia? 147 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 147 reports of Covid-19 pneumonia have been filed in association with CASIRIVIMAB\IMDEVIMAB. This represents 3.5% of all adverse event reports for CASIRIVIMAB\IMDEVIMAB.

147
Reports of Covid-19 pneumonia with CASIRIVIMAB\IMDEVIMAB
3.5%
of all CASIRIVIMAB\IMDEVIMAB reports
9
Deaths
123
Hospitalizations

How Dangerous Is Covid-19 pneumonia From CASIRIVIMAB\IMDEVIMAB?

Of the 147 reports, 9 (6.1%) resulted in death, 123 (83.7%) required hospitalization, and 3 (2.0%) were considered life-threatening.

Is Covid-19 pneumonia Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for CASIRIVIMAB\IMDEVIMAB. However, 147 reports have been filed with the FAERS database.

What Other Side Effects Does CASIRIVIMAB\IMDEVIMAB Cause?

Infusion related reaction (875) Dyspnoea (687) Nausea (416) Oxygen saturation decreased (390) Dizziness (357) Pyrexia (306) Chest discomfort (294) Chills (265) Flushing (238) Cough (235)

What Other Drugs Cause Covid-19 pneumonia?

RITUXIMAB (1,489) DEXAMETHASONE (758) LENALIDOMIDE (750) PREDNISONE (749) OCRELIZUMAB (669) TACROLIMUS (622) MYCOPHENOLATE MOFETIL (594) PREDNISOLONE (479) METHOTREXATE (472) CYCLOPHOSPHAMIDE (430)

Which CASIRIVIMAB\IMDEVIMAB Alternatives Have Lower Covid-19 pneumonia Risk?

CASIRIVIMAB\IMDEVIMAB vs CASPOFUNGIN CASIRIVIMAB\IMDEVIMAB vs CATEQUENTINIB CASIRIVIMAB\IMDEVIMAB vs CC-4047 CASIRIVIMAB\IMDEVIMAB vs CEDAZURIDINE\DECITABINE CASIRIVIMAB\IMDEVIMAB vs CEDIRANIB

Related Pages

CASIRIVIMAB\IMDEVIMAB Full Profile All Covid-19 pneumonia Reports All Drugs Causing Covid-19 pneumonia CASIRIVIMAB\IMDEVIMAB Demographics